Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001093518 | SCV001250551 | uncertain significance | Phenylketonuria | 2020-01-26 | reviewed by expert panel | curation | The c.1002C>T (p.Cys334=) variant in PAH has not been reported in the literature to our knowledge. This variant has an extremely low frequency in ExAC, gnomAD, and ESP (MAF=0.00004). Multiple lines of computational evidence are conflicting regarding splicing impact (Potential alteration of splicing in HSF, TraP=0.058). In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PM2. |
Eurofins Ntd Llc |
RCV000317688 | SCV000340191 | uncertain significance | not provided | 2016-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001093518 | SCV001668436 | likely benign | Phenylketonuria | 2024-01-21 | criteria provided, single submitter | clinical testing |